K14-HPV16 transgenic mice develop epidermal hyperplastic lesions that progress to dysplastic lesions and ultimately to invasive cancer, which is in line with the occurrence and progress of clinical cervical cancer 47, 48. This evidence concerns the gene KRT14 and cervical carcinoma.